Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
25-08-2026 20:49 via prnewswire.com

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes

Libre Duo 10 Day is a first-of-its-kind, two-in-one biowearable that monitors glucose and helps detect rising ketone levels that can lead to diabetic ketoacidosis (DKA), a serious health condition for people living with diabetes Designed to seamlessly address a critical gap in ketone...
Read more »

PR Public relations news



/C O R R E C T I O N -- OPAQUE/
/C O R R E C T I O N -- OPAQUE/
AMPERA UND DAS LAWRENCE LIVERMORE NATIONAL LABORATORY GEBEN STRATEGISCHE PARTNERSCHAFT ZUR ENTWICKLUNG FORTSCHRITTLICHER KERNBRENNSTOFFE BEKANNT
AMPERA UND DAS LAWRENCE LIVERMORE NATIONAL LABORATORY GEBEN STRATEGISCHE PARTNERSCHAFT ZUR ENTWICKLUNG FORTSCHRITTLICHER KERNBRENNSTOFFE BEKANNT
Robbins LLP Reminds PLNT Investors of the Pending Lead Plaintiff Deadline in the Securities Class Action Lawsuit Against Planet Fitness, Inc.
Robbins LLP Reminds PLNT Investors of the Pending Lead Plaintiff Deadline in the Securities Class Action Lawsuit Against Planet Fitness, Inc.
Custom Home Builder Expert Cole Glascock Explains How to Design a Lake of the Ozarks Home in HelloNation
Custom Home Builder Expert Cole Glascock Explains How to Design a Lake of the Ozarks Home in HelloNation
TBLA Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Taboola.com Ltd.
TBLA Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Taboola.com Ltd.
New Dx World Summit to Unite the Global Diagnostics Ecosystem in Washington, D.C., August 23-25, 2027
New Dx World Summit to Unite the Global Diagnostics Ecosystem in Washington, D.C., August 23-25, 2027
Greenberg Traurig Deploys the Next Generation of CoCounsel Legal
Greenberg Traurig Deploys the Next Generation of CoCounsel Legal
Capital Group Announces Appointment of New Chief Information Officer
Capital Group Announces Appointment of New Chief Information Officer
AMPERA ET LE LABORATOIRE NATIONAL LAWRENCE LIVERMORE ANNONCENT UN PARTENARIAT STRATÉGIQUE POUR LE DÉVELOPPEMENT DE COMBUSTIBLES NUCLÉAIRES DE NOUVELLE GÉNÉRATION
AMPERA ET LE LABORATOIRE NATIONAL LAWRENCE LIVERMORE ANNONCENT UN PARTENARIAT STRATÉGIQUE POUR LE DÉVELOPPEMENT DE COMBUSTIBLES NUCLÉAIRES DE NOUVELLE GÉNÉRATION
Action1 Expands Endpoint Management with New Configuration Management and Enrollment and Provisioning Modules
Action1 Expands Endpoint Management with New Configuration Management and Enrollment and Provisioning Modules
Robbins LLP Urges PNR Stockholders Who Lost Money Investing in Pentair plc. To Contact the Firm for Information About Leading the Class Action
Robbins LLP Urges PNR Stockholders Who Lost Money Investing in Pentair plc. To Contact the Firm for Information About Leading the Class Action
Horticulture Co., a Leading U.S. Beverage Company focused on Hemp-Derived THC and Functional Adult Beverages, Sees Tremendous Success From 112.5% YoY Growth to Expansion into New Markets, Securement of New Retailers Including ABC Fine Wine & Spiri
Horticulture Co., a Leading U.S. Beverage Company focused on Hemp-Derived THC and Functional Adult Beverages, Sees Tremendous Success From 112.5% YoY Growth to Expansion into New Markets, Securement of New Retailers Including ABC Fine Wine & Spiri
Horticulture Co., a Leading U.S. Beverage Company focused on Hemp-Derived THC and Functional Adult Beverages, Sees Tremendous Success From 112.5% YoY Growth to Expansion into New Markets, Securement of New Retailers Including ABC Fine Wine & Spiri
Horticulture Co., a Leading U.S. Beverage Company focused on Hemp-Derived THC and Functional Adult Beverages, Sees Tremendous Success From 112.5% YoY Growth to Expansion into New Markets, Securement of New Retailers Including ABC Fine Wine & Spiri
Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
Desktop versie